Amplia Therapeutics Ltd banner

Amplia Therapeutics Ltd
ASX:ATX

Watchlist Manager
Amplia Therapeutics Ltd Logo
Amplia Therapeutics Ltd
ASX:ATX
Watchlist
Price: 0.135 AUD Market Closed
Market Cap: AU$69.3m

Wall St Price Targets

ATX Price Targets Summary
Amplia Therapeutics Ltd

Wall Street analysts forecast ATX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ATX is 0.428 AUD with a low forecast of 0.424 AUD and a high forecast of 0.441 AUD.

Lowest Forecast
Price Target
0.424 AUD
214% Upside
Average Forecast
Price Target
0.428 AUD
217% Upside
Highest Forecast
Price Target
0.441 AUD
227% Upside
Amplia Therapeutics Ltd Competitors:
Price Targets
INO
Inovio Pharmaceuticals Inc
422% Upside
LAND
Gladstone Land Corp
26% Upside
UFPT
UFP Technologies Inc
49% Upside
VINP
Vinci Partners Investments Ltd
42% Upside
CSGP
CoStar Group Inc
58% Upside

Revenue
Forecast

25% / Year
Past Growth
39% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
25% / Year
Past Growth
39% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 12 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 3 years is 39%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is ATX's stock price target?
Price Target
0.428 AUD

According to Wall Street analysts, the average 1-year price target for ATX is 0.428 AUD with a low forecast of 0.424 AUD and a high forecast of 0.441 AUD.

What is the Revenue forecast for Amplia Therapeutics Ltd?
Projected CAGR
39%

Over the last 12 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 3 years is 39%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett